te Sun Pharma: Today Latest News, Photos, Videos about Sun Pharma - Zee Business

हिंदी में पढ़ें

Sun Pharma

Sun Pharma to fully acquire subsidiary Taro Pharma for Rs 2,892 crore; shares rise

Sun Pharma to fully acquire subsidiary Taro Pharma for Rs 2,892 crore; shares rise

Thu, Jan 18, 2024

On Thursday, Sun Pharma shares ended weaker by Rs 14.3, or 1.1 per cent, at Rs 1,299.3 apiece.

Sun Pharma inks pact with Bayer to sell drug for chronic kidney disease

Sun Pharma inks pact with Bayer to sell drug for chronic kidney disease

Wed, Jan 17, 2024

Under the terms of the agreement, Bayer has granted non-exclusive rights to Sun Pharma to market and distribute a second Finerenone product under the brand name Lyvelsa. Finerenone was first launched by Bayer under the brand name Kerendia in 2022.

Sun Pharma Shares Hit 52-Week High Post Acquiring Israel's Libra Merger Ltd | Stock Market News

Sun Pharma Shares Hit 52-Week High Post Acquiring Israel's Libra Merger Ltd | Stock Market News

Wed, Jan 03, 2024

Sun Pharma hits a new high after acquiring Israel's Libra Merger, consolidating its presence in the region. This follows a recent US investment in Lyndra Therapeutics. We break down the deals and their potential impact on Sun Pharma's future.

TRENDING NOW

Sun Pharma, Lupin recall drugs in US market: USFDA

Sun Pharma, Lupin recall drugs in US market: USFDA

Sun, Dec 17, 2023

Mumbai-based Sun Pharmaceutical Industries is recalling 96,192 bottles of Liothyronine Sodium Tablets in the US that are used to treat an underactive thyroid, according to the latest enforcement report issued by the American health regulator.

Sun Pharma revises upwards price to fully acquire Taro to USD 43 per share

Sun Pharma revises upwards price to fully acquire Taro to USD 43 per share

Tue, Dec 12, 2023

Sun Pharmaceutical Industries on Tuesday said it has revised upwards the price at which it proposed to fully acquire Israel-based Taro Pharmaceutical Industries to USD 43 per share in cash.

Sun Pharma inks licensing pact with Aclaris Therapeutics

Sun Pharma inks licensing pact with Aclaris Therapeutics

Wed, Dec 06, 2023

Aclaris Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel drugs for immuno-inflammatory diseases.

D-Street Newsmakers: L&T, Sun Pharma, JSPL and MRPL among 10 stocks that buzzed the most today

D-Street Newsmakers: L&T, Sun Pharma, JSPL and MRPL among 10 stocks that buzzed the most today

Wed, Nov 01, 2023

Sectorally, it was a mixed session, with metal pack emerging as the top laggard, while realty index was the outperformed.

Sun Pharma Q2 net up 5% at Rs 2,375 crore

Sun Pharma Q2 net up 5% at Rs 2,375 crore

Wed, Nov 01, 2023

Sun Pharmaceutical Industries on Wednesday said its consolidated net profit increased by 5 per cent to Rs 2,375 crore for the second quarter ended September 30, driven by robust sales across domestic and US markets.

How will be the results of SunPharma?

How will be the results of SunPharma?

Tue, Oct 31, 2023

How will SunPharma's results be? How will be the growth in domestic formulations? How much income is possible from America? Know complete details from Nupur.

Zydus, Sun Pharma ink licensing pact to co-market CKD treatment drug

Zydus, Sun Pharma ink licensing pact to co-market CKD treatment drug

Mon, Oct 30, 2023

Under the terms of the agreement, Zydus has granted Sun Pharma semi-exclusive rights to co-market the product in India, it stated.

Sun Pharma to buyout local partner in Mexican arm

Sun Pharma to buyout local partner in Mexican arm

Thu, Sep 28, 2023

The company has signed a binding letter of intent to acquire the balance 25 per cent outstanding shares of Sun Pharma de Mexico, SA de CV, a subsidiary where it currently holds 75 per cent shares, Sun Pharmaceutical Industries said in a regulatory filing.

Sun Pharma unit inks licensing pact with US-based firm to introduce drug to treat stroke

Sun Pharma unit inks licensing pact with US-based firm to introduce drug to treat stroke

Thu, Sep 14, 2023

As per agreement terms, Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide), the company said.

Sun Pharma aims to spend 7-8% of sales on R&D this fiscal

Sun Pharma aims to spend 7-8% of sales on R&D this fiscal

Mon, Aug 28, 2023

Addressing shareholders during the Annual General Meeting (AGM), Managing Director Dilip Shanghvi said the company did well in all its geographies last fiscal, recording double-digit growth.

Sun Pharma slips over 1% after June quarter numbers; Top brokerages' view

Sun Pharma slips over 1% after June quarter numbers; Top brokerages' view

Fri, Aug 04, 2023

Sun Pharma Q1 Review: Total income rose to Rs 12,145 crore in the first quarter as against Rs 10,764 crore in the year-ago period, Sun Pharma said in a regulatory filing.

Sun Pharma Q1 Results: Net profit falls to Rs 2,022 crore

Sun Pharma Q1 Results: Net profit falls to Rs 2,022 crore

Thu, Aug 03, 2023

The company said its adjusted net profit (excluding the exceptional items) for the June quarter stood at Rs 2,345 crore, up 14 per cent over the same period last year.

Sun Pharma, Alembic recall drugs in US market due to manufacturing issues

Sun Pharma, Alembic recall drugs in US market due to manufacturing issues

Sun, Jul 30, 2023

As per the US health regulator's latest Enforcement Report, the Mumbai-based drug major is recalling 12,336 bottles of Buprenorphine Sublingual tablets, used for treating opioid use disorder, in the American market. Sun Pharmaceutical Industries Inc, the US-based arm of the company, is recalling the affected lot (8 mg, 30 count-bottles) due to CGMP (Current Good Manufacturing Practice) deviations

Sun Pharma gets clearance for acne control cream from Canadian regulator; shares decline

Sun Pharma gets clearance for acne control cream from Canadian regulator; shares decline

Tue, Jun 20, 2023

Sun Pharma share price BSE: Sun Pharmaceutical Industries Ltd, NSE: Sun Pharma shares received approval of Health Canada — the country’s health regulator — for its WINLEVI cream, used in treating certain skin diseases.

Sun Pharma proposes to fully acquire Israel-based Taro Pharmaceutical Industries

Sun Pharma proposes to fully acquire Israel-based Taro Pharmaceutical Industries

Sat, May 27, 2023

Sun Pharmaceutical Industries on Saturday said it has proposed to fully acquire Israel-based Taro Pharmaceutical Industries through a reverse triangular merger.

Sun Pharma dividend: Drug major announces 400% payout

Sun Pharma dividend: Drug major announces 400% payout

Fri, May 26, 2023

Sun Pharma dividend: Sun Pharmaceutical announced a final dividend of Rs 4 per equity share — a 400 per cent payout given the face value of Re 1 per share.

Sun Pharma swings to profit in Q4; firm declares final dividend of Rs 4

Sun Pharma swings to profit in Q4; firm declares final dividend of Rs 4

Fri, May 26, 2023

Sun Pharma Q4 results: The bottom line was in-line with Zee Business analysts' estimates. Zee Business Research had projected the company to report a profit after tax (PAT) of Rs 1,982 crore for the January-March period.

Sun Pharma Q4 results today: Check top-line, bottom-line estimates and key things to watch out for

Sun Pharma Q4 results today: Check top-line, bottom-line estimates and key things to watch out for

Thu, May 25, 2023

Sun Pharma Q4 preview: The company is expected to report a profit after tax (PAT) of Rs 1,982 crore for the January-March period against a loss of Rs 2,277 crore registered in the corresponding quarter of the preceding fiscal.

Gainers and Losers: Top 10 stocks that buzzed the most today

Gainers and Losers: Top 10 stocks that buzzed the most today

Wed, May 10, 2023

Gainers and Losers: BSE Sensex closed the session at 61,940.20, up 179 points, or 0.29 per cent. Here's what brokerages recommend.

Should you buy, sell or hold Pidilite Industries, Kansai Nerolac, Exide Industries, UPL, Mahanagar Gas other stocks today?

Should you buy, sell or hold Pidilite Industries, Kansai Nerolac, Exide Industries, UPL, Mahanagar Gas other stocks today?

Tue, May 09, 2023

Which stocks to buy, hold or sell today? As Dalal Street enters the May 3 session, here's a look at what brokerages make of some of the key stocks trending today. Stocks such as Pidilite Industries, Kansai Nerolac, Mahanagar Gas Limited, Exide Industries, UPL, Sun Pharma and other shares are on their radar today.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x